Drug Discovery Technologies Market 2018 Research In-Depth Analysis, Applications, Forecasts To 2024

1
Drug Discovery Technologies Market Global
Industry Analysis, Trends, Market Size and
Forecasts up to 2024
2
The report on Drug Discovery Technologies Market
by technology type (biochips, high throughput
screening, pharmacogenomics, genomics,
bioanalytical instruments, bioinformatics,
nanotechnology), end users (biopharmaceutical,
pharmaceutical, research institutes and biotech
companies) trends analysis and forecasts up to
2024 studies the market sizes, key trends
and opportunities in the main geographies such
as North America, Europe, Asia-Pacific, Rest
of the World. According to the report the
Global Drug Discovery Technologies Market is
projected to grow at a CAGR of 18.4 in terms of
value over the period of 2018-2024. The growth
in the world market is primarily driven by
significant contribution by North America
(Leading region) region to this market. Market
Insight The growing incidences of diseases,
pathogen resistance to old drugs, patent
expiries, and competition among drug
manufacturers are the key factors that drive the
growth of this market. Moreover, increasing
investment in the field of nanotechnology,
biotechnology, genomics, and, molecular biology
are some other factor that has driven this
market. Furthermore, long duration of drug
discovery process, high initial setup cost
and presence of strict regulatory
surroundings. Segments Covered The report on
global drug discovery technologies market covers
segments such as technology type, and end users.
The technology type segments include
biochips, high throughput screening,
pharmacogenomics, genomics, bioanalytical
instruments, bioinformatics, nanotechnology
and others (RNAI, combinatorial chemistry).
On the basis of end users the global
drug discovery technologies market is
categorized into biopharmaceutical companies,
pharmaceutical companies, research institutes and
biotech companies.
3
Geographic Coverage The report provides regional
analysis covering geographies such as North
America, Europe, Asia-Pacific, and Rest of the
World. In this section the key trends and market
size for each geography is provided over the
period of 2016 2024. The countries
covered in the North America region include
the U.S., Canada, and Mexico while
Asia-Pacific includes China, Japan, India,
South Korea and Malaysia among others. The
U.S. drives the growth in the North America
region as it is the largest market in the region.
The Asia-pacific region offers a substantial
potential for the market growth owing to rapid
growth in markets such as India and China. The
APAC region is projected to experience a growth
at a CAGR of x.x over the period of 2018 -
2024. Companies Profiled The report provides
profiles of the companies in the global
drug discovery technologies market such as,
Agilent Technologies, Inc, Abbott
Laboratories, Inc., GE Healthcare Ltd.,
Albany Molecular Research Inc., Affymetrix
Inc., Arqule Inc., Luminex Corporation, Bayer
Healthcare AG, Novartis AG, and Astrazeneca
plc. Get a Sample Request https//www.infiniumgl
obalresearch.com/reports/sample_request/1128 Repo
rt Highlights The report provides deep insights
on demand forecasts, market trends and micro and
macro indicators. In addition, this report
provides insights on the factors that are driving
and restraining the global drug discovery
technologies market. Moreover, IGR-Growth
Matrix analysis given in the report brings
an insight on the investment areas that
existing or new market players can
consider. The report provides insights into
the market using analytical tools such as
Porters five forces analysis and DRO
analysis of drug discovery technologies market.
4

• Moreover, the study highlights current market
  trends and provides forecast from 2018 to 2024.
  We also have highlighted future trends in the
  drug discovery technologies market that will
  impact the demand during the forecast period.
  Moreover, the competitive analysis given in each
  regional market brings an insight on the market
  share of the leading players. Additionally, the
  analysis highlights rise and fall in the market
  shares of the key players in the market.
  This report will help manufacturers,
  suppliers and distributors of the drug
  discovery technologies market to understand the
  present and future trends in this market and
  formulate their strategies accordingly.
• Make an Enquiry https//www.infiniumglobalresearc
  h.com/reports/enquiry/1128
• Table of Contends
• Preface
• Report Description
• Research Methods
• Research Approaches
• Executive Summary
• Global Drug Discovery Technologies Market
  Overview
• Introduction
• Market Dynamics

5

• 3.2.1Drivers
• Restraints
• Opportunities
• Porters Five Forces Analysis
• IGR Growth Matrix Analysis
• Competitive Landscape in the Global Drug
  Discovery Technologies Market
• Global Drug Discovery Technologies Market by
  Technology Type 2018 - 2024
• Biochips
• High throughput screening
• Pharmacogenomics
• Genomics
• Bioanalytical instruments
• Bioinformatics
• Nanotechnology

6

• 4.8 Others (RNAi, combinatorial chemistry)
• Global Drug Discovery Technologies Market by End
  Users 2018 - 2024
• Biopharmaceutical companies
• Pharmaceutical companies
• Research institutes
• Biotech companies
• Click the Below Full Report https//www.infiniumg
  lobalresearch.com/healthcare_medical_devices/globa
  l_drug_discovery_technologie s_market
• Companies Covered
• Agilent Technologies, Inc
• Abbott Laboratories, Inc.
• GE Healthcare Ltd.
• Albany Molecular Research Inc.

7

1. Affymetrix Inc.
2. Arqule Inc.
3. Luminex Corporation
4. Bayer Healthcare AG
5. Novartis AG
6. Astrazeneca plc